H Demuynck
- Hematology top 1%
- Oncology top 5%
- Genetics top 5%
- Infectious Diseases top 5%
- Epidemiology top 10%
- Co-authors
- M. BoogaertsPierre ZachéeAugustin FerrantPeter VandenbergheDavid C. LinchAlan BargePeter DregerHartmut Link
- Topics
- Hematopoietic Stem Cell Transplantation (14 papers)Acute Myeloid Leukemia Research (10 papers)Neutropenia and Cancer Infections (9 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
H Demuynck
38 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 82
- Hematology 884
- Oncology 484
- Genetics 297
- Infectious Diseases 266
- Epidemiology 256
Countries citing papers authored by H Demuynck
This map shows the geographic impact of H Demuynck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Demuynck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Demuynck more than expected).
Fields of papers citing papers by H Demuynck
This network shows the impact of papers produced by H Demuynck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Demuynck. The network helps show where H Demuynck may publish in the future.
Co-authorship network of co-authors of H Demuynck
This figure shows the co-authorship network connecting the top 25 collaborators of H Demuynck. A scholar is included among the top collaborators of H Demuynck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Demuynck. H Demuynck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 32 | |
| 5 | 19 | |
| 6 | 2 | |
| 7 | 154 | |
| 8 | Intensive non-myeloablative chemotherapy can induce GvHD and complete remission in patients with AML/MDS relapsing after allo-BMT | 1 |
| 9 | 11 | |
| 10 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) fails to improve outcome in invasive fungal infections in neutropenic cancer patients | 1 |
| 11 | Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors. | 31 |
| 12 | Intensive chemotherapy followed by autologous progenitor cell transplantation may lead to prolonged hematological and molecular remission in chronic lymphocytic leukemia (CLL) | 1 |
| 13 | Treatment of primary amyloidosis with VAD combination chemotherapy results in improved survival | 5 |
| 14 | 37 | |
| 15 | 31 | |
| 16 | 3 | |
| 17 | 8 | |
| 18 | 12 | |
| 19 | 42 | |
| 20 | 43 |
About H Demuynck
H Demuynck is a scholar working on Hematology, Genetics and Oncology, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (10 papers) and Neutropenia and Cancer Infections (9 papers). The work is most often cited by research in Hematology (884 citations), Genetics (297 citations) and Oncology (484 citations). H Demuynck has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include M. Boogaerts, Pierre Zachée, Augustin Ferrant, Peter Vandenberghe, David C. Linch, Alan Barge, Peter Dreger, Hartmut Link, Norbert Schmitz and Keith M. Borkett. Their work appears in journals such as The Lancet, Blood and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.